-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PT Raised to $192 at Baird
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Added To Baird's Fresh Pick List Ahead of June PFE Data
-
-
-
-
-
-
-
Baird Reiterates Outperform on Sarepta Therapeutics (SRPT)
-
-
-
-
-
-
-
Baird 'Strong Buyers' of Sarepta Therapeutics (SRPT) on FAERS Weakness
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT): Neurologist Survey Results - Baird
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Shares Make Strong Move Off Session Lows
-
-
-
-
-
-
-
Baird Affirms Sarepta Therapeutics (SRPT) at 'Outperform'; Incrementally Positive on PTAB Decision (BMRN)
-
22,948 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All